Evaluate the Efficacy and Safety of Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia
NCT04233918
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Homozygous Familial Hypercholesterolemia
Interventions
DRUG:
Evinacumab
Sponsor
Regeneron Pharmaceuticals